Associations of killer cell immunoglobulin like receptors with rheumatoid arthritis among North Indian population

Human Immunology

Volumn 75, Issue 8, 2014, Pages 802-807

  Prakash, Swayam ^a   Alam, Shahnawaz ^a   Bharadwaj, Uddalak ^b   Aggarwal, Amita ^a   Mishra, Ram Nath ^a   Agrawal, Suraksha ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmune disease; Genetic association; Killer immunoglobulin like receptor (KIR); Polymerase chain reaction sequence specific primer (PCR SSP); Rheumatoid arthritis (RA)

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DP1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; UNCLASSIFIED DRUG; ISOPROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIAN; JOINT FUNCTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE DIFFERENCE; RANGE OF MOTION; RHEUMATOID ARTHRITIS; ALLELE; CASE CONTROL STUDY; GENE EXPRESSION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; INDIA; MIDDLE AGED; NATURAL KILLER CELL; PATHOLOGY; SYNOVIUM;

ADULT; AGED; ALLELES; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMANS; INDIA; KILLER CELLS, NATURAL; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; RECEPTORS, KIR; SYNOVIAL MEMBRANE;

EID: 84905090076     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.05.014     Document Type: Article

References (31)

1. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011, 365(23):2205-2219.
2. Ritchlin C.T. Mechanisms of erosion in rheumatoid arthritis. J Rheumatol 2004, 31:1229-1237.
3. Pridgeon C., Lennon G.P., Pazmany L., Thompson R.N., Christmas S.E., Moots R.J. Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56 bright, CD94 bright, CD158 negative phenotype. Rheumatology 2003, 42(7):870-878.
4. Namekawa T., Snyder M.R., Yen J.H., Goehring B.E., Leibson P.J., Weyand C.M., et al. Killer Cell activating receptors function as costimulatory molecules on CD4+CD8 null T cells clonally expanded in Rheumatoid Arthritis. J Immunol 2000, 165(2):1138-1145.
5. Brennan F.M., McInnes I.B. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008, 118(11):3537-3545.
6. Karsh J., Dorval G., Osterland C.K. Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 1981, 19:437-446.
7. Combe B., Pope R., Darnell B., Talal N. Modulation of natural killer cell activity in the rheumatoid joint and peripheral blood. Scand J Immunol 1984, 20:551-558.
8. Lipsky P.E. Natural killer cell function in rheumatoid arthritis. Clin Exp Rheumatol 1986, 4:303-305.
9. Yen J.-H., Moore B.E., Nakajima T., Scholl D., Schaid D.J., Weyand C.M., et al. Major histocompatibility complex class I-recognising receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001, 193:1159-1167.
10. Uhrberg M., Valiante N.M., Shum B.P., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997, 7:753-763.
11. Hsu K.C., Chida S., Geraghty D.E., Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002, 190:40-52.
12. Weyand C.M., Goronzy J.J., Liuzzo G., Kopecky S.L., Holmes D.R., Frye R.L. T-cell immunity in acute coronary syndromes. Mayo Clin Proc 2001, 76:1011-1020.
13. Dalbeth N., Cullan M.F. A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum 2002, 46:1763-1772.
14. Yen J.H., Lin C.H., Tsai W.C., Wu C.C., Ou T.T., Hu C.J., et al. Killer cell immunoglobulin-like receptor genes repertoire in rheumatoid arthritis. Scand J Rheumatol 2006, 35:124-127.
15. Miyashita R., Tsuchiya N., Matsuta K., Yabe T., Tokunaga K. An association study: KIR and HLA genotypes in the Japanese patients with rheumatoid arthritis. Abstract from 8th Annual Meeting of Society for Natural Immunity 2004, 56. Karger AG, Basel.
16. Nelson G.W., Martin M.P., Gladman D., Wade J., Trowsdale J., Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004, 173:4273-4276.
17. Williams F., Meenagh A., Sleator C., Cook D., Fernandez-Vina M., Bowcock A.M., et al. Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum Immunol 2005, 66:836-841.
18. Suzuki Y., Hamamoto Y., Ogasawara Y., Ishikawa K., Yoshikawa Y., Sasazuki T., et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J Invest Dermatol 2004, 122:1133-1136.
19. Łuszczek W., Mańczak M., Cisło M., Nockowski P., Wiśniewski A., Jasek M., et al. Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum Immunol 2004, 65:758-766.
20. Vilches C., Castano J., Gomez-Lozano N., Estefania E. Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens 2007, 70(5):415-422.
21. Murdoch S., Soed M., Kircheisen R., Mazhar B., Slim R. Detailed gene and allele content analysis of three homozygous KIR haplotypes. Tissue Antigens 2006, 68(1):72-77.
22. Mavropoulos A., Rigopoulou E.I., Liaskos C., Bogdanos D.P., Sakkas L.I. The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis. Clin Dev Immunol 2013, 2013:569751.
23. Fasth A.E., Björkström N.K., Anthoni M., Malmberg K.J., Malmström V. Activating NK-cell receptors co-stimulate CD4+CD28- T cells in patients with rheumatoid arthritis. Eur J Immunol 2010, 40(2):378-387.
24. Gonzalez-Galarza F.F., Christmas S., Middleton D., Jones A.R. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acid Res 2011, 39:D913-D919.
25. Yen J.H., Moore B.E., Nakajima T., Scholl D., Schaid D.J., Weyand C.M., et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001, 193(10):1159-1167.
26. Middleton D., Meenagh A., Wright G.D. No association in frequency of KIR receptors in patients with rheumatoid arthritis from Northern Ireland. Tissue Antigens 2007, 69(6):577-582.
27. Flodström-Tullberg M., Bryceson Y.T., Shi F.D., Höglund P., Ljunggren H.G. Natural killer cells in human autoimmunity. Curr Opin Immunol 2009, 21(6):634-640.
28. Rajagopalan S., Long E.O. Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 2005, 201(7):1025-1029.
29. Fadda L., Borhis G., Ahmed P., Cheent K., Pageon S.V., Cazaly A., et al. Peptide antagonismas a mechanism for NK cell activation. Proc Natl Acad Sci USA 2010, 107(22):10160-10165.
30. Matsui T., Otsuka M., Maenaka K., Furukawa H., Yabe T., Yamamoto K., et al. Detection of autoantibodies to killer immunoglobulin like receptors using recombinant fusion proteins for two killer immunoglobulin-like receptors in patients with systemic autoimmune diseases. Arthritis Rheum 2001, 44(2):384-388.
31. Ramírez-De los Santos S., Sánchez-Hernández P.E., Muñoz-Valle J.F., Palafox-Sánchez C.A., Rosales-Rivera L.Y., García-Iglesias T., et al. Associations of killer cell immunoglobulin like receptor genes with rheumatoid arthritis. Dis Markers 2012, 33:201-206.